Follow
Sofia Sagredou
Sofia Sagredou
Verified email at med.uoa.gr
Title
Cited by
Cited by
Year
The continuum of thyroid disorders related to immune checkpoint inhibitors: Still many pending queries
MV Deligiorgi, S Sagredou, L Vakkas, DT Trafalis
Cancers 13 (21), 5277, 2021
152021
8-Hydroxy-2’-Deoxyguanosine and 8-nitroguanine production and detection in blood serum of breast cancer patients in response to postoperative complementary external ionizing …
KE Verigos, S Sagredou, K Orfanakos, P Dalezis, DT Trafalis
Dose-Response 18 (4), 1559325820982172, 2020
62020
Discovery of steroidal lactam conjugates of POPAM-NH2 with potent anticancer activity
D Trafalis, P Dalezis, E Geromichalou, S Sagredou, E Sflakidou, M Voura, ...
Future Medicinal Chemistry 12 (1), 19-35, 2020
62020
3,6-Disubstituted 1,2,4-Triazolo[3,4-b]Thiadiazoles with Anticancer Activity Targeting Topoisomerase II Alpha
S Sagredou, P Dalezis, N Nikoleousakos, M Nikolaou, M Voura, ...
OncoTargets and therapy, 7369-7386, 2020
52020
Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation
DT Trafalis, S Sagredou, P Dalezis, M Voura, S Fountoulaki, ...
Pharmaceutics 13 (4), 493, 2021
42021
Azasteroid Alkylators as dual inhibitors of AKT and ERK signaling for the treatment of ovarian carcinoma
P Dalezis, E Geromichalou, A Polonifi, S Sagredou, N Nikoleousakos, ...
Cancers 12 (5), 1263, 2020
42020
Cytocidal Antitumor Effects against Human Ovarian Cancer Cells Induced by B-Lactam Steroid Alkylators with Targeted Activity against Poly (ADP-Ribose) Polymerase (PARP) Enzymes …
N Nikoleousakos, P Dalezis, A Polonifi, EG Geromichalou, S Sagredou, ...
Biomedicines 9 (8), 1028, 2021
22021
Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden
S Sagredou, P Dalezis, E Papadopoulou, M Voura, MV Deligiorgi, ...
Pharmaceutics 13 (6), 885, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–8